BMGL
Basel Medical Group Ltd provides healthcare services. The company offers services in the areas of medical specialists, medical supplies and equipment, medical technology, and pharmaceuticals. The company was incorporated in 2023 and is based in Singapore.
Basel Medical Group Ltd (BMGL) is rated C+ (2.6/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (B+); its weakest is Momentum (F).
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-17 | B- (3.0) | B+ (3.8) | B- (3.0) | F (0.6) | C+ (2.6) | C+ (2.6) |
| 2026-11-10 | B- (3.0) | A- (3.9) | B- (3.0) | C- (2.0) | C+ (2.6) | B- (2.9) |
| 2026-11-03 | B- (3.0) | A- (4.0) | B- (3.1) | D+ (1.8) | C+ (2.7) | B- (2.9) |
| 2026-10-27 | B- (3.0) | A- (4.1) | C (2.2) | D (1.3) | C+ (2.6) | C+ (2.6) |
| 2026-10-20 | B- (3.0) | A- (4.1) | C (2.2) | D (1.4) | C+ (2.6) | C+ (2.7) |